| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 213.81▲ | 213.81▲ | 213.58▲ | 212.56▲ | 223.25▼ |
| MA10 | 213.69▲ | 213.57▲ | 213.68▲ | 212.43▲ | 234.84▼ |
| MA20 | 213.75▲ | 213.43▲ | 213.16▲ | 221.73▼ | 238.84▼ |
| MA50 | 213.55▲ | 213.13▲ | 212.11▲ | 236.08▼ | 207.08▲ |
| MA100 | 213.48▲ | 212.18▲ | 217.04▼ | 239.40▼ | 164.27▲ |
| MA200 | 213.03▲ | 218.54▼ | 227.39▼ | 215.51▼ | 144.92▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.016▲ | 0.033▲ | 0.040▲ | 0.051▲ | -6.917▼ |
| RSI | 56.095▲ | 54.891▲ | 54.650▲ | 36.998▼ | 42.511▼ |
| STOCH | 69.055 | 69.719 | 61.102 | 31.585 | 12.833▼ |
| WILL %R | -36.752 | -29.769 | -26.439 | -75.446▼ | -87.782▼ |
| CCI | 180.285▲ | 70.081 | 66.620 | -36.526 | -163.433▼ |
|
Wednesday, September 30, 2026 11:47 AM
Nuvation Bio NUVB) stock and Jazz Pharmaceuticals (JAZZ) stock gain as Citi issues new Buy ratings on the firms based on their cancer treatments. Read more here.
|
|
Wednesday, September 30, 2026 11:45 AM
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the pharmaceuticals industry, including Jazz Pharmaceuticals (NASDAQ:JAZZ) and its peers.
|
|
Wednesday, September 30, 2026 11:45 AM
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the pharmaceuticals industry, including Jazz Pharmaceuticals (NASDAQ:JAZZ) and its peers.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 23/10/26 | 213.09 | 215.35 | 211.49 | 214.00 | 560,601 |
| 22/10/26 | 211.38 | 215.24 | 210.26 | 214.65 | 783,806 |
| 21/10/26 | 213.75 | 215.13 | 211.53 | 211.97 | 695,844 |
| 20/10/26 | 209.89 | 215.545 | 208.98 | 213.76 | 663,214 |
| 19/10/26 | 209.595 | 210.57 | 206.71 | 208.43 | 702,919 |
| 16/10/26 | 214.25 | 214.775 | 208.15 | 210.23 | 636,102 |
| 15/10/26 | 212.19 | 217.57 | 212.19 | 214.42 | 886,400 |
| 14/10/26 | 210.34 | 215.66 | 209.36 | 209.65 | 891,300 |
| 13/10/26 | 216.86 | 216.86 | 209.34 | 210.39 | 812,575 |
| 12/10/26 | 218.90 | 221.99 | 216.57 | 216.75 | 739,600 |
|
|
||||
|
|
||||
|
|